IDXX Q3 2019 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q3 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$605M+11.0% YoY

Gross Profit

$345M57.0% margin

Operating Income

$140M23.1% margin

Net Income

$109M18.0% margin

EPS (Diluted)

$1.24

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$132M

Free Cash Flow

$95M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.5B

Stockholders' Equity

$202M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$605M	$545M	+11.0%
Gross Profit	$345M	$306M	+12.9%
Operating Income	$140M	$117M	+19.1%
Net Income	$109M	$93M	+16.7%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$1.6B96%

Reagent Rental Programs

$31M2%

Extended Warranties And Post Contract Support

$24M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$380M79%

Asia Pacific

$65M13%

CANADA

$24M5%

Latin America

$14M3%